Appeals court upholds ‘pharma bro’ Martin Shkreli lifetime ban from drug industry
A federal appeals court Tuesday upheld a lifetime ban on “pharma bro” Martin Shkreli from working in the pharmaceuticals industry…
High-end brothels serviced elected officials, tech and pharma execs, military brass: Feds
A network of “sophisticated” high-end brothels in greater Boston and eastern Virginia provided sex for pay to “elected officials, high…
Mississippi Gov. Tate Reeves faces challenger Brandon Presley, Democrat who ran on expanding Medicaid
Mississippi Gov. Tate Reeves, a Republican, faces a surprisingly competitive race Tuesday as his Democratic challenger Brandon Presley champions expanding…
Republican Reps. Kay Granger, Ken Buck announce they won’t seek reelection
Republican Rep. Ken Buck of Colorado on Wednesday announced he will not seek reelection next year, saying he was “disappointed”…
Mike Johnson elected House speaker, putting Louisiana Republican in the spotlight
Republican Rep. Mike Johnson of Louisiana was elected speaker of the House of Representatives on Wednesday, ending a three-week leadership…
Eight Republicans are vying to become the next House speaker. These are the candidates
Deeply divided Republican lawmakers this week are trying to coalesce around a nominee for speaker of the House of Representatives…
Jim Jordan loses second House speaker vote, as GOP weighs dwindling options
Rep. Jim Jordan’s bid to become speaker of the U.S. House of Representatives failed Wednesday for the second time in…
Jim Jordan’s House Speaker bid gains momentum as Biden warns of ‘dangerous’ leadership vacuum in Congress
Rep. Jim Jordan of Ohio rallied fresh support Monday for his bid to become the next speaker of the House…
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News…
Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
Pfizer on Friday slashed its full-year earnings and revenue guidance and launched a $3.5 billion cost-cutting plan due to waning…
